CAP Certification
Proud to announce we’ve earned our CAP certification! A reflection of our unwavering commitment to maintaining the highest standards.
ASGCT23
We’re thrilled to announce our participation in ASGCT23 (American Society of Gene and Cell Therapy Annual Meeting). We invite you to visit our booth, #803, where you can learn more about our cutting-edge solutions and services.
PBMC Isolation
Welcome to our video tutorial on isolating peripheral blood mononuclear cells (PBMC) from whole blood using CPT tubes. In this step-by-step guide, we will walk you through the process of obtaining high-quality PBMC for your research or clinical applications.
We’re expanding our team.
We’re expanding our team. We are looking for dedicated, motivated and creative individuals to join Accurant!
New office space lease just signed!
Analysis of Biomarker Bioanalysis Method Development and Validation Strategies
Biomarkers have always been one of the hot topics in the field of drug research and development. Especially in the past decade, with the increasing attention to product innovation and research and development efficiency, the application of biomarkers has become more and more medicine. An indispensable part of the R&D strategy of enterprises and biotech companies.
The Method of Improving Drug Tolerance in The ADA Testing Process
Almost all biopharmaceutical products will cause a certain anti-drug antibody (ADA) response after entering the body, which refers to immune response. ADA may affect or change the pharmacodynamic effect between the therapeutic protein and its target. Its pharmacokinetic characteristics affect the efficacy of the drug, and in some cases may also cause serious adverse reactions and even endanger the life of the patient.
Overcome the Difficulties of Bioanalysis in the Application of Gene Therapy Drugs with AAV as a Vector
The concept of gene therapy was proposed in the early 1970s. The original concept was to introduce a normal copy of a gene to replace a mutated counterpart. Although there are now more alternatives, such as gene editing and base editing, it is still one of the main strategies that Accurant Biotech Inc., applies.
